Your browser doesn't support javascript.
loading
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.
Bastian, Lorenz; Hartmann, Alina M; Beder, Thomas; Hänzelmann, Sonja; Kässens, Jan; Bultmann, Miriam; Hoeppner, Marc P; Franzenburg, Sören; Wittig, Michael; Franke, Andre; Nagel, Inga; Spielmann, Malte; Reimer, Niklas; Busch, Hauke; Schwartz, Stefan; Steffen, Björn; Viardot, Andreas; Döhner, Konstanze; Kondakci, Mustafa; Wulf, Gerald; Wendelin, Knut; Renzelmann, Andrea; Kiani, Alexander; Trautmann, Heiko; Neumann, Martin; Gökbuget, Nicola; Brüggemann, Monika; Baldus, Claudia D.
Afiliación
  • Bastian L; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Hartmann AM; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Beder T; Clinical Research Unit "CATCH-ALL" (KFO 5010/1), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bonn, Germany.
  • Hänzelmann S; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kässens J; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Bultmann M; Clinical Research Unit "CATCH-ALL" (KFO 5010/1), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bonn, Germany.
  • Hoeppner MP; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Franzenburg S; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Wittig M; Clinical Research Unit "CATCH-ALL" (KFO 5010/1), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bonn, Germany.
  • Franke A; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Nagel I; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Spielmann M; Clinical Research Unit "CATCH-ALL" (KFO 5010/1), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bonn, Germany.
  • Reimer N; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Busch H; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Schwartz S; Medical Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Steffen B; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Viardot A; Clinical Research Unit "CATCH-ALL" (KFO 5010/1), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Bonn, Germany.
  • Döhner K; Institute for Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Kondakci M; Institute for Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Wulf G; Institute for Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Wendelin K; Institute for Clinical Molecular Biology, Kiel University, Kiel, Germany.
  • Renzelmann A; Institute of Human Genetics, University Medical Center Schleswig-Holstein, Kiel & Lübeck, Germany.
  • Kiani A; Institute of Human Genetics, University Medical Center Schleswig-Holstein, Kiel & Lübeck, Germany.
  • Trautmann H; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Lübeck/Kiel, 23538, Lübeck, Germany.
  • Neumann M; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
  • Gökbuget N; Medical Systems Biology Group and Institute for Cardiogenetics, University of Lübeck, Lübeck, Germany.
  • Brüggemann M; University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
  • Baldus CD; University Cancer Center Schleswig-Holstein, University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
Leukemia ; 36(6): 1676-1680, 2022 06.
Article en En | MEDLINE | ID: mdl-35397658
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Fusión Génica Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Fusión Génica Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania